Related Experiment Video
Updated: Jul 9, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Multivariate Markov process models for the transmission of methicillin-resistant Staphylococcus aureus in a hospital
1School of Mathematical Sciences, Queensland University of Technology, GPO Box 2434, Brisbane 4001, Australia.
Abstract:
Methicillin-resistant Staphylococcus Aureus (MRSA) is a pathogen that continues to be of major concern in hospitals. We develop models and computational schemes based on observed weekly incidence data to estimate MRSA transmission parameters. We extend the deterministic model of McBryde, Pettitt, and McElwain (2007, Journal of Theoretical Biology 245, 470-481) involving an underlying population of MRSA colonized patients and health-care workers that describes, among other processes, transmission between uncolonized patients and colonized health-care workers and vice versa. We develop new bivariate and trivariate Markov models to include incidence so that estimated transmission rates can be based directly on new colonizations rather than indirectly on prevalence. Imperfect sensitivity of pathogen detection is modeled using a hidden Markov process. The advantages of our approach include (i) a discrete valued assumption for the number of colonized health-care workers, (ii) two transmission parameters can be incorporated into the likelihood, (iii) the likelihood depends on the number of new cases to improve precision of inference, (iv) individual patient records are not required, and (v) the possibility of imperfect detection of colonization is incorporated. We compare our approach with that used by McBryde et al. (2007) based on an approximation that eliminates the health-care workers from the model, uses Markov chain Monte Carlo and individual patient data. We apply these models to MRSA colonization data collected in a small intensive care unit at the Princess Alexandra Hospital, Brisbane, Australia.
Insights
New Markov models estimate Methicillin-resistant Staphylococcus Aureus (MRSA) transmission rates using incidence data. This approach improves precision by directly analyzing new colonizations and accounting for imperfect detection in healthcare settings.
Area of Science:
- Epidemiology
- Mathematical Biology
- Infectious Disease Modeling
Background:
- Methicillin-resistant Staphylococcus Aureus (MRSA) poses a significant threat in hospital environments.
- Accurate estimation of MRSA transmission dynamics is crucial for effective control strategies.
Purpose of the Study:
- To develop and validate novel computational models for estimating MRSA transmission parameters.
- To improve upon existing deterministic models by incorporating incidence data directly and accounting for imperfect detection.
Main Methods:
- Extension of the McBryde, Pettitt, and McElwain deterministic model.
- Development of bivariate and trivariate Markov models incorporating incidence data.
- Modeling imperfect pathogen detection sensitivity using a hidden Markov process.
Main Results:
- The new models allow for direct estimation of transmission rates from new colonizations, enhancing precision.
- The approach incorporates a discrete-valued assumption for colonized healthcare workers and allows for two transmission parameters.
- Comparison with previous methods highlights advantages in precision and data requirements, not needing individual patient records.
Conclusions:
- The developed Markov models provide a more precise and flexible framework for estimating MRSA transmission parameters.
- The models effectively handle imperfect detection and can be applied to real-world healthcare data, as demonstrated in an ICU setting.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Steps in Outbreak Investigation
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission of Pathogens
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
